AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/142
CD95 (APO-1 FAS) MUTATIONS IN CHILDHOOD T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA/
Authors: BELTINGER C KURZ E BOHLER T SCHRAPPE M LUDWIG WD DEBATIN KM
Citation: C. Beltinger et al., CD95 (APO-1 FAS) MUTATIONS IN CHILDHOOD T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA/, Blood, 91(10), 1998, pp. 3943-3951
IMMUNOPHENOTYPE AND CLINICAL CHARACTERISTICS OF CD45-NEGATIVE AND CD45-POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: RATEI R SPERLING C KARAWAJEW L SCHOTT G SCHRAPPE M HARBOTT J RIEHM H LUDWIG WD
Citation: R. Ratei et al., IMMUNOPHENOTYPE AND CLINICAL CHARACTERISTICS OF CD45-NEGATIVE AND CD45-POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Annals of hematology, 77(3), 1998, pp. 107-114
SEQUENCE-ANALYSIS OF THE FIRST HTLV-I INFECTION IN GERMANY WITHOUT RELATIONS TO ENDEMIC AREAS
Authors: ELLERBROK H FLEISCHER C SALEMI M REINHARDT P LUDWIG WD VANDAMME AM PAULI G
Citation: H. Ellerbrok et al., SEQUENCE-ANALYSIS OF THE FIRST HTLV-I INFECTION IN GERMANY WITHOUT RELATIONS TO ENDEMIC AREAS, AIDS research and human retroviruses, 14(13), 1998, pp. 1199-1203
HIGH-RATE OF CHROMOSOME-ABNORMALITIES DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION USING BCR AND ABL PROBES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: RIEDER H BONWETSCH C JANSSEN LAJ MAURER J JANSSEN JWG SCHWARTZ S LUDWIG WD GASSMANN W BARTRAM CR THIEL E LOFFLER H GOKBUGET N HOELZER D FONATSCH C
Citation: H. Rieder et al., HIGH-RATE OF CHROMOSOME-ABNORMALITIES DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION USING BCR AND ABL PROBES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 12(9), 1998, pp. 1473-1481
EXPRESSION AND REGULATION OF C-KIT RECEPTOR AND RESPONSE TO STEM-CELLFACTOR IN CHILDHOOD MALIGNANT T-LYMPHOBLASTIC CELLS
Authors: TOMECZKOWSKI J FRICK D SCHWINZER B WITTNER N LUDWIG WD REITER A WELTE K SYKORA KW
Citation: J. Tomeczkowski et al., EXPRESSION AND REGULATION OF C-KIT RECEPTOR AND RESPONSE TO STEM-CELLFACTOR IN CHILDHOOD MALIGNANT T-LYMPHOBLASTIC CELLS, Leukemia, 12(8), 1998, pp. 1221-1229
SUPERIORITY OF HIGH-DOSE OVER INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF PATIENTS WITH HIGH-RISK ACUTE MYELOID-LEUKEMIA - RESULTS OF AN AGE-ADJUSTED PROSPECTIVE RANDOMIZED COMPARISON
Authors: KERN W AUL C MASCHMEYER G SCHONROCKNABULSI R LUDWIG WD BARTHOLOMAUS A BETTELHEIM P WORMANN B BUCHNER T HIDDEMANN W
Citation: W. Kern et al., SUPERIORITY OF HIGH-DOSE OVER INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF PATIENTS WITH HIGH-RISK ACUTE MYELOID-LEUKEMIA - RESULTS OF AN AGE-ADJUSTED PROSPECTIVE RANDOMIZED COMPARISON, Leukemia, 12(7), 1998, pp. 1049-1055
DETECTION OF HYPERDIPLOID KARYOTYPES (GREATER-THAN-50 CHROMOSOMES) INCHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) USING FLUORESCENCE IN-SITU HYBRIDIZATION (FISH)
Authors: RITTERBACH J HIDDEMANN W BECK JD SCHRAPPE M JANKASCHAUB G LUDWIG WD HARBOTT J LAMPERT F
Citation: J. Ritterbach et al., DETECTION OF HYPERDIPLOID KARYOTYPES (GREATER-THAN-50 CHROMOSOMES) INCHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) USING FLUORESCENCE IN-SITU HYBRIDIZATION (FISH), Leukemia, 12(3), 1998, pp. 427-433
ANTIBODIES TC-12 (UNIQUE) AND TH-111 (CD96) CHARACTERIZE T-CELL ACUTELYMPHOBLASTIC-LEUKEMIA AND A SUBGROUP OF ACUTE MYELOID-LEUKEMIA
Authors: GRAMATZKI M LUDWIG WD BURGER R MOOS P ROHWER P GRUNERT C SENDLER A KALDEN JR ANDREESEN R HENSCHKE F MOLDENHAUER G
Citation: M. Gramatzki et al., ANTIBODIES TC-12 (UNIQUE) AND TH-111 (CD96) CHARACTERIZE T-CELL ACUTELYMPHOBLASTIC-LEUKEMIA AND A SUBGROUP OF ACUTE MYELOID-LEUKEMIA, Experimental hematology, 26(13), 1998, pp. 1209-1214
THE ROLE OF CD95 (APO-1 FAS) MUTATIONS IN LYMPHOPROLIFERATIVE DISORDERS AND LYMPHATIC MALIGNANCIES/
Authors: BELTINGER C BOHLER T SCHRAPPE M LUDWIG WD DEBATIN KM
Citation: C. Beltinger et al., THE ROLE OF CD95 (APO-1 FAS) MUTATIONS IN LYMPHOPROLIFERATIVE DISORDERS AND LYMPHATIC MALIGNANCIES/, Klinische Padiatrie, 210(4), 1998, pp. 153-158
THE ROLE OF BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY INRELAPSING ACUTE LYMPHOCYTIC-LEUKEMIA
Authors: FREUND M HEIL G ARNOLD R BALLEISEN L BUCHNER T DIEDRICH H EIMERMACHER H FONATSCH C GANSER A GASSMANN W HARTMANN F HIDDEMANN W KASPER C KNAUF WU KOCH P KUBICA U LINK H LOFFLER H LUDWIG WD MASCHMEYER G POMPE K SCHADECK C SCHMITZ N SCHONROCKNABULSI P SCHWONZEN M THIEL E WEISS A HOELZER D
Citation: M. Freund et al., THE ROLE OF BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY INRELAPSING ACUTE LYMPHOCYTIC-LEUKEMIA, Bone marrow transplantation, 22, 1998, pp. 10-10
PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD
Authors: VANDONGEN JJM SERIU T PANZERGRUMAYER ER BIONDI A PONGERSWILLEMSE MJ CORRAL L STOLZ F SCHRAPPE M MASERA G KAMPS WA GADNER H VANWERING ER LUDWIG WD BASSO G DEBRUIJN MAC CAZZANIGA G HETTINGER A VANDERDOESVANDENBERG A HOP WCJ RIEHM H BARTRAM CR
Citation: Jjm. Vandongen et al., PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD, Lancet, 352(9142), 1998, pp. 1731-1738
MUTATION ANALYSIS OF CD95 (APO-1 FAS) IN CHILDHOOD B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA/
Authors: BELTINGER C BOHLER T KARAWAJEW L LUDWIG WD SCHRAPPE M DEBATIN KM
Citation: C. Beltinger et al., MUTATION ANALYSIS OF CD95 (APO-1 FAS) IN CHILDHOOD B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA/, British Journal of Haematology, 102(3), 1998, pp. 722-728
CLINICAL-SIGNIFICANCE OF CD95 AND BCL-2 EXPRESSION AND FUNCTIONALITY IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: WUCHTER C KARAWAJEW L RUPPERT V SCHRAPPE M DORKEN B LUDWIG WD
Citation: C. Wuchter et al., CLINICAL-SIGNIFICANCE OF CD95 AND BCL-2 EXPRESSION AND FUNCTIONALITY IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 113-113
INVOLVEMENT OF BCL-2 AND BAX IN THE APOPTOSIS MODULATION BY IL-7 IN CHILDHOOD T-ALL
Authors: RUPPERT V KOSSER A LIEBEZEIT K DORKEN B LUDWIG WD KARAWAJEW L
Citation: V. Ruppert et al., INVOLVEMENT OF BCL-2 AND BAX IN THE APOPTOSIS MODULATION BY IL-7 IN CHILDHOOD T-ALL, British Journal of Haematology, 102(1), 1998, pp. 113-113
IL-7, IL-4 AND IL-2 REVEAL DIFFERENTIAL-EFFECTS ON APOPTOSIS, BUT DO NOT AFFECT CELL-CYCLE IN CHILDHOOD T-ALL CELLS IN-VITRO
Authors: KARAWAJEW L RUPPERT V KOSSER A SCHRAPPE M GANZEL K MARTIN M DORKEN B LUDWIG WD
Citation: L. Karawajew et al., IL-7, IL-4 AND IL-2 REVEAL DIFFERENTIAL-EFFECTS ON APOPTOSIS, BUT DO NOT AFFECT CELL-CYCLE IN CHILDHOOD T-ALL CELLS IN-VITRO, British Journal of Haematology, 102(1), 1998, pp. 114-114
5 CHILDREN AND 7 ADULTS WITH CD7- ACUTE NATURAL-KILLER-CELL LEUKEMIA(CD56+ CD3)
Authors: SPAHN G SPERLING C BUCHNER T CREUTZIG U SCHLEGELBERGER B HARBOTT J DOHNER H DORKEN B LUDWIG WD
Citation: G. Spahn et al., 5 CHILDREN AND 7 ADULTS WITH CD7- ACUTE NATURAL-KILLER-CELL LEUKEMIA(CD56+ CD3), British Journal of Haematology, 102(1), 1998, pp. 114-114
TEL AML1 GENE FUSION IS NOT ASSOCIATED WITH IN-VITRO DRUG-SENSITIVITYIN ACUTE LYMPHOBLASTIC VITRO DRUG LEUKEMIA/
Authors: RAMAKERSVANWOERDEN NL PIETERS R KAZEMIER KM VANDRUNEN E HARBOTT J SEYFERT J BEVERLOO HB SLATER R VANWERING ER LUDWIG WD JANKASCHAUB G SCHMIEGELOW K VEERMAN AJP
Citation: Nl. Ramakersvanwoerden et al., TEL AML1 GENE FUSION IS NOT ASSOCIATED WITH IN-VITRO DRUG-SENSITIVITYIN ACUTE LYMPHOBLASTIC VITRO DRUG LEUKEMIA/, British Journal of Haematology, 102(1), 1998, pp. 231-231
IN-VITRO DRUG-RESISTANCE PROFILE IN MLL-GENE REARRANGED INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT
Authors: RAMAKERSVANWOERDEN NL PIETERS R BEVERLOO HB LOONEN AH SLATER R VANWERING ER LUDWIG WD HARBOTT J JANKASCHAUB G SCHMIEGELOW K VEERMAN AJP
Citation: Nl. Ramakersvanwoerden et al., IN-VITRO DRUG-RESISTANCE PROFILE IN MLL-GENE REARRANGED INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT, British Journal of Haematology, 102(1), 1998, pp. 232-232
TCR-GAMMA-DELTA(-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS - V-DELTA-1 AND NON-V-DELTA-1 EXPRESSING CASES REPRESENT DISTINCT MATURATION STAGES() T)
Authors: LANGERAK AW WOLVERSTETTERO ILM VANDENBEEMD MWM VANWERING ER LUDWIG WD HAHLEN K NECKER A VANDONGEN JJM
Citation: Aw. Langerak et al., TCR-GAMMA-DELTA(-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS - V-DELTA-1 AND NON-V-DELTA-1 EXPRESSING CASES REPRESENT DISTINCT MATURATION STAGES() T), British Journal of Haematology, 102(1), 1998, pp. 274-274
IMMUNOPHENOTYPIC AND CLINICAL-FEATURES OF T-CELL RECEPTOR GAMMA-DELTA(-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA() T)
Authors: SCHOTT G SPERLING C SCHRAPPE M RATEI R MARTIN M MEYER U RIEHM H LUDWIG WD
Citation: G. Schott et al., IMMUNOPHENOTYPIC AND CLINICAL-FEATURES OF T-CELL RECEPTOR GAMMA-DELTA(-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA() T), British Journal of Haematology, 101(4), 1998, pp. 753-755
CORRELATION OF CYTOGENETIC, MOLECULAR CYTOGENETIC, AND CLINICAL FINDINGS IN 59 PATIENTS WITH ANLL OR MDS AND ABNORMALITIES OF THE SHORT ARMOF CHROMOSOME-12
Authors: STREUBEL B SAUERLAND C HEIL G FREUND M BARTELS H LENGFELDER E WANDT H LUDWIG WD NOWOTNY H BALDUS M GROTHAUSPINKE B BUCHNER T FONATSCH C
Citation: B. Streubel et al., CORRELATION OF CYTOGENETIC, MOLECULAR CYTOGENETIC, AND CLINICAL FINDINGS IN 59 PATIENTS WITH ANLL OR MDS AND ABNORMALITIES OF THE SHORT ARMOF CHROMOSOME-12, British Journal of Haematology, 100(3), 1998, pp. 521-533
IMMUNOPHENOTYPIC AND GENOTYPIC FEATURES, CLINICAL CHARACTERISTICS, AND TREATMENT OUTCOME OF ADULT PRO-B ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF THE GERMAN MULTICENTER TRIALS GMALL 03 87 AND 04/89/
Authors: LUDWIG WD RIEDER H BARTRAM CR HEINZE B SCHWARTZ S GASSMANN W LOFFLER H HOSSFELD D HEIL G HANDT S HEYLL A DIEDRICH H FISCHER K WEISS A VOLKERS B AYDEMIR U FONATSCH C GOKBUGET N THIEL E HOELZER D
Citation: Wd. Ludwig et al., IMMUNOPHENOTYPIC AND GENOTYPIC FEATURES, CLINICAL CHARACTERISTICS, AND TREATMENT OUTCOME OF ADULT PRO-B ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF THE GERMAN MULTICENTER TRIALS GMALL 03 87 AND 04/89/, Blood, 92(6), 1998, pp. 1898-1909
THE RELIABILITY AND SPECIFICITY OF C-KIT FOR THE DIAGNOSIS OF ACUTE MYELOID LEUKEMIAS AND UNDIFFERENTIATED LEUKEMIAS
Authors: BENE MC BERNIER M CASASNOVAS RO CASTOLDI G KNAPP W LANZA F LUDWIG WD MATUTES E ORFAO A SPERLING C VANTVEER MB
Citation: Mc. Bene et al., THE RELIABILITY AND SPECIFICITY OF C-KIT FOR THE DIAGNOSIS OF ACUTE MYELOID LEUKEMIAS AND UNDIFFERENTIATED LEUKEMIAS, Blood, 92(2), 1998, pp. 596-599
MLL AND CALM ARE FUSED TO AF10 IN MORPHOLOGICALLY DISTINCT SUBSETS OFACUTE-LEUKEMIA WITH TRANSLOCATION T(10-11) - BOTH REARRANGEMENTS ARE ASSOCIATED WITH A POOR-PROGNOSIS
Authors: DREYLING MH SCHRADER K FONATSCH C SCHLEGELBERGER B HAASE D SCHOCH C LUDWIG WD LOFFLER H BUCHNER T WORMANN B HIDDEMANN W BOHLANDER SK
Citation: Mh. Dreyling et al., MLL AND CALM ARE FUSED TO AF10 IN MORPHOLOGICALLY DISTINCT SUBSETS OFACUTE-LEUKEMIA WITH TRANSLOCATION T(10-11) - BOTH REARRANGEMENTS ARE ASSOCIATED WITH A POOR-PROGNOSIS, Blood, 91(12), 1998, pp. 4662-4667
USE OF GA-67-SPECT IN PATIENTS WITH MALIG NANT-LYMPHOMA FOLLOWING PRIMARY CHEMOTHERAPY FOR FURTHER TREATMENT PLANNING - COMPARISON WITH SPIRAL CT
Authors: STROSZCZYNSKI C AMTHAUER H HOSTER N MAPARA M RICKE J JOCHENS R FISCHERFUNK E LUDWIG WD EICHSTADT H FELIX R
Citation: C. Stroszczynski et al., USE OF GA-67-SPECT IN PATIENTS WITH MALIG NANT-LYMPHOMA FOLLOWING PRIMARY CHEMOTHERAPY FOR FURTHER TREATMENT PLANNING - COMPARISON WITH SPIRAL CT, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 167(5), 1997, pp. 458-466
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>